Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel L Suzman

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2003
Extensive retinal neovascularization as a late finding in human immunodeficiency virus-infected patients with immune recovery uveitisMary E Wright, Daniel L Suzman, Karl G Csaky, et al.
The Oncologist|March 18, 2016
FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based ChemotherapyDickran Kazandjian, Daniel L Suzman, Gideon Blumenthal, et al.
The Prostate|August 27, 2015
Optimal sequencing of docetaxel and abiraterone in men with metastatic castration-resistant prostate cancerBenjamin L Maughan, Xian C Xhou, Daniel L Suzman, et al.
Journal of the National Cancer Institute|July 1, 2024
RE: Is it time to reconsider the role of upfront cytoreductive nephrectomy in metastatic renal cell carcinoma?Jaleh Fallah, Haley Gittleman, Chana Weinstock, et al.
Annals of Hematology|November 16, 2013
Sustained remission and reversal of end-organ dysfunction in a patient with anaplastic myelomaMridul Agrawal, Jennifer Kanakry, Christina A Arnold, et al.
Journal of the National Cancer Institute|March 15, 2024
Cytoreductive nephrectomy in the era of immune checkpoint inhibitors: a US Food and Drug Administration pooled analysisJaleh Fallah, Haley Gittleman, Chana Weinstock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2026
FDA Approval Summary: Durvalumab for the Treatment of Adult Patients with Muscle Invasive Bladder CancerNooshin Mirkheshti, Daniel Edem Kpormegbey, Chana Weinstock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2024
FDA Approval Summary: Nadofaragene Firadenovec-vncg for Bacillus Calmette-Guérin-Unresponsive Non-Muscle-Invasive Bladder CancerLaronna Colbert, Yuxia Jia, Anurag Sharma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2023
FDA Approval Summary: Belzutifan for VHL Disease Tumors-ResponseJaleh Fallah, Chana Weinstock, Gautam U Mehta, et al.
AIDS (London, England)|August 19, 2004
Serious ophthalmic pathology compromising vision in HCV/HIV co-infected patients treated with peginterferon alpha-2b and ribavirinClaire Farel, Daniel L Suzman, Mary McLaughlin, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2003
Extensive retinal neovascularization as a late finding in human immunodeficiency virus-infected patients with immune recovery uveitisMary E Wright, Daniel L Suzman, Karl G Csaky, et al.
The Oncologist|March 18, 2016
FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based ChemotherapyDickran Kazandjian, Daniel L Suzman, Gideon Blumenthal, et al.
The Prostate|August 27, 2015
Optimal sequencing of docetaxel and abiraterone in men with metastatic castration-resistant prostate cancerBenjamin L Maughan, Xian C Xhou, Daniel L Suzman, et al.
Journal of the National Cancer Institute|July 1, 2024
RE: Is it time to reconsider the role of upfront cytoreductive nephrectomy in metastatic renal cell carcinoma?Jaleh Fallah, Haley Gittleman, Chana Weinstock, et al.
Annals of Hematology|November 16, 2013
Sustained remission and reversal of end-organ dysfunction in a patient with anaplastic myelomaMridul Agrawal, Jennifer Kanakry, Christina A Arnold, et al.
Journal of the National Cancer Institute|March 15, 2024
Cytoreductive nephrectomy in the era of immune checkpoint inhibitors: a US Food and Drug Administration pooled analysisJaleh Fallah, Haley Gittleman, Chana Weinstock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2026
FDA Approval Summary: Durvalumab for the Treatment of Adult Patients with Muscle Invasive Bladder CancerNooshin Mirkheshti, Daniel Edem Kpormegbey, Chana Weinstock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2024
FDA Approval Summary: Nadofaragene Firadenovec-vncg for Bacillus Calmette-Guérin-Unresponsive Non-Muscle-Invasive Bladder CancerLaronna Colbert, Yuxia Jia, Anurag Sharma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2023
FDA Approval Summary: Belzutifan for VHL Disease Tumors-ResponseJaleh Fallah, Chana Weinstock, Gautam U Mehta, et al.
AIDS (London, England)|August 19, 2004
Serious ophthalmic pathology compromising vision in HCV/HIV co-infected patients treated with peginterferon alpha-2b and ribavirinClaire Farel, Daniel L Suzman, Mary McLaughlin, et al.
Pageof 5